Results 1 to 10 of about 1,217,759 (290)

Drivers of and Barriers to COVID-19 Vaccine Booster Dose Acceptance in Indonesia

open access: yesVaccines, 2022
Obtaining a booster dose of coronavirus disease 2019 (COVID-19) vaccine is required to maintain the protective level of neutralizing antibodies and therefore herd immunity in the community, and the success of booster dose programs depends on public ...
Harapan Harapan   +25 more
doaj   +4 more sources

A survey on Malaysian’s acceptance and perceptions towards COVID-19 booster dose [PDF]

open access: yesSaudi Pharmaceutical Journal, 2023
Progressive reopening of the economy and declaration of COVID-19 as endemic has relaxed social distancing and mask-wearing necessities in Malaysia. The Ministry of Health of Malaysia reported vaccination rate had reached 86.1% for the first dose and 84.3%
Suresh Rajakumar   +4 more
doaj   +3 more sources

Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study

open access: yesVaccines, 2022
SARS-CoV-2 (COVID-19) vaccines are critical for containing serious infections. However, as COVID-19 evolves toward more transmissible varieties and serum antibody levels in vaccinated persons steadily decline over time, the likelihood of breakthrough ...
Walid Al-Qerem   +4 more
doaj   +4 more sources

Efficacy of HBV booster dose administration in Italian medical students in relation to health determinants [PDF]

open access: yesHuman Vaccines & Immunotherapeutics
We evaluated the efficacy of a booster dose of HBV in Italian medical students. We conducted a prospective observational study in students who had received a full course of anti-HBV vaccination for at least 15 y.
Loreta Tobia   +7 more
doaj   +3 more sources

Facilitators and Barriers to Take up a COVID-19 Vaccine Booster Dose among Community-Dwelling Older Adults in Hong Kong: A Population-Based Random Telephone Survey

open access: yesVaccines, 2022
A COVID-19 vaccine booster dose is effective and safe for older adults. This study investigated facilitators and barriers to take up a COVID-19 vaccine booster dose among older adults in Hong Kong.
Zixin Wang   +5 more
doaj   +3 more sources

Factors associated with COVID-19 booster dose uptake in the Jazan region, Saudi Arabia: insights for policy improvement during pandemics [PDF]

open access: yesFrontiers in Public Health
ObjectivesThis study aimed to assess factors associated with COVID-19 booster dose uptake in the Jazan region, Saudi Arabia.MethodsA sample of 467 individuals participated in a cross-sectional online questionnaire between February and March 2022.
Mohammed J. Almalki   +3 more
doaj   +2 more sources

Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland [PDF]

open access: yesVaccines, 2021
COVID-19 vaccinations are essential to mitigate the pandemic and prevent severe SARS-CoV-2 infections. However, the serum antibody levels in vaccinated individuals gradually decrease over time, while SARS-CoV-2 is undergoing an evolution toward more transmissible variants, such as B.1.617.2, ultimately increasing the risk of breakthrough infections and
Barbara Poniedziałek   +2 more
exaly   +4 more sources

Comparison of humoral immune response in heterologous and homologous COVID-19 booster vaccine groups using CoronaVac and mRNA-based BNT162b2 vaccines [PDF]

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 2023
Background: Heterologous COVID-19 booster vaccination is an alternative strategy to homologous vaccination, especially in developing countries, due to shortages, delays, or unequal distribution of COVID-19 vaccines.
Serkan Atıcı   +8 more
doaj   +1 more source

The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What

open access: yesVaccines, 2022
With the emergence of SARS-CoV-2 variants, vaccine breakthrough is a major public health concern. With evidence of reduced neutralizing antibody activity against Omicron variants and fading antibody level after the third-dose booster vaccine, there are ...
Ka-Wa Khong   +2 more
doaj   +1 more source

A tale of two conditions: when people living with HIV meet three doses of inactivated COVID-19 vaccines

open access: yesFrontiers in Immunology, 2023
BackgroundCurrently, data on long-term immune responses to a homogenous booster dose of the inactivated COVID-19 vaccine are still limited among people living with HIV (PLWH).MethodsA prospective cohort study with a 13-month follow-up was conducted in ...
Yuting Tan   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy